Intraperitoneal Delivery of Adaptive Natural Killer (NK) Cells (FATE-NK100) with Intraperitoneal Interleukin- 2 in Women with Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
|Effective start/end date||7/1/17 → 7/30/22|
- Fate Therapeutics
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.